Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

1. The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals (Ed. M. J. O’Neil), 14th ed., Merck Publishing Group, Merck & Co., Inc., Whitehouse Station 2006.Search in Google Scholar

2. D. S. P. Byrav, B. Medhi, A. Prakash, S. Patyar and S. Wadhwa, Lornoxicam: A newer NSAID, Indian J. Phys. Med. Rehabil. 20 (2009) 27-31.Search in Google Scholar

3. F. B. Riecke, E. M. Bartels, S. Torp-Pedersen, S. Ribel-Madsen, H. Bliddal, B. Danneskiold-Samsoe and L. Arendt-Nielsen, A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery, Res. Pharm. Sci. 1 (2011) 76-79; DOI: 10.1016/j. rinphs.2011.11.001.Search in Google Scholar

4. G. Yener, M. Uner, U. Gonullu, S. Yıldırım, P. Kılıc, S. Sağlık Aslan and A. Barla, Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies, Chem. Pharm. Bull. 58 (2010) 1466-1473; DOI: 10.1248/cpb.58.1466.10.1248/cpb.58.1466Search in Google Scholar

5. M. Uner, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems, Pharmazie 61 (2006) 375-386.Search in Google Scholar

6. M. Uner and G. Yener, Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives, Int. J. Nanomed. 2 (2007) 289-300.Search in Google Scholar

7. S. A. Wissing, A. Lippacher and R. H. Muller, Investigations on the occlusive properties of solid lipid nanoparticles (SLN), J. Cosmet. Sci. 52 (2001) 313-324.Search in Google Scholar

8. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu and X. Yang, Podophyllotoxinloaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.10.1016/j.jconrel.2005.09.052Search in Google Scholar

9. C. Puglia, P. Blasi, L. Rizza, A. Schoubben, F. Bonina, C. Rossi and M. Ricci, Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation, Int. J. Pharm. 357 (2008) 295-304; DOI: 10.1016/j.ij pharm.2008.01.045.Search in Google Scholar

10. S. Kuchler, N. B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M. M. Yahya, C. Stein and M. Schafer- Korting, 3D-wound healing model: influence of morphine and solid lipid nanoparticles, J. Biotechnol. 148 (2010) 24-30; DOI: 10.1016/j.jbiotec.2010.01.001.10.1016/j.jbiotec.2010.01.001Search in Google Scholar

11. V. Sanna, G. Caria and A. Mariani, Eff ect of lipid nanoparticles containing fa_ y alcohols having diff erent chain length on the ex vivo skin permeability of econazole nitrate, Powder Technol. 201 (2010) 32-36; DOI: 10.1016/j.powtec.2010.02.035. 10.1016/j.powtec.2010.02.035Search in Google Scholar

12. E. B. Souto, C. Anselmi, M. Centini and R. H. Muller, Preparation and characterization of n-dodecyl- ferulate-loaded solid lipid nanoparticles (SLNR), Int. J. Pharm. 295 (2005) 261-268; DOI: 10.1016/j.ij pharm.2005.02.005.Search in Google Scholar

13. M. Ghadiri, S. Fatemi, A. Vatanara, D. Doroud, A. R. Najafabadi, M. Darabi and A. A. Rahimi, Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment effi ciency and particle size, Int. J. Pharm. 424 (2012) 128-137; DOI: 10.1016/j.ij pharm.2011.12.037.Search in Google Scholar

14. Y. C. Kuo and H. H. Chen, Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles, Int. J. Pharm. 365 (2009) 206-213; DOI: 10.1016/j.ij pharm.2008.08.050.Search in Google Scholar

15. O. W. Sto_ , A. C. Williams and B. W. Barry, Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen, J. Control. Release 50 (1998) 297-308; DOI: 10.1016/S0168-3659(97)00153-3.10.1016/S0168-3659(97)00153-3Search in Google Scholar

16. J. L. Ford and P. Timmins, Pharmaceutical Thermal Analysis, Ellis Horwood, Chichester 1989.Search in Google Scholar

17. B. Siekmann and K. Westesen, Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles, Colloids Surf., B. Biointerfaces 3 (1994) 159-175; DOI: 10.1016/0927-7765(94)80063-4.10.1016/0927-7765(94)80063-4Search in Google Scholar

18. J. Pardeike, S. Webera, T. Haber, J. Wagner, H. P. Zarfl , H. Plank and A. Zimmer, Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application, Int. J. Pharm. 419 (2011) 329-338; DOI: 10.1016/j.ij pharm.2011.07.040.Search in Google Scholar

19. D. Z. Hou, C. S. Xie, K. J. Huang and C. H. Zhu, The production and characteristics of solid-lipid nanoparticles (SLNs), Biomaterials 34 (2003) 1781-1785; DOI: 10.1016/S0142-9612(02)00578-1.10.1016/S0142-9612(02)00578-1Search in Google Scholar

20. S. Das, W. K. Ng and R. B. H. Tan, Are nanostructured lipid carriers (NLCs) be_ er that solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole- loaded SLNs and NLCs?, Eur. J. Pharm. Sci. 47 (2012) 139-151; DOI: 10.1016/j.ejps.2012.05.010.10.1016/j.ejps.2012.05.010Search in Google Scholar

21. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

22. R. W. Korsmeyer, R. Gurney, E. M. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35. DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9Search in Google Scholar

23. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70 (2008) 633-640; DOI: 10.1016/j.ejpb.2008.05.008.10.1016/j.ejpb.2008.05.008Search in Google Scholar

24. M. Joshi and V. Patravale, Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132; DOI: 10.1016/j.ij pharm.2007.05.060.Search in Google Scholar

25. A. Zur Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism, Eur. J. Pharm. Biopharm. 45 (1998) 149-155; DOI: 10.1016/S0939-6411(97)00150-1.10.1016/S0939-6411(97)00150-1Search in Google Scholar

26. K. Bhaskar, J. Anbu, V. Ravichandiran, V. Venkatesvarlu and Y. M. Rao, Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies, Lipids Health Dis. 8 (2009) 1-15; DOI: 10.1186/1476-511X-8-6.10.1186/1476-511X-8-6265188119243632Search in Google Scholar

27. S. K. Jain, M. K. Chourasia, R. Masuriha, V. Soni, A. Jain, N. K. Jain and Y. Gupta, Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery, Drug Deliv. 12 (2005) 207-215; DOI: 10.1080/10717540590952591. 10.1080/1071754059095259116036715Search in Google Scholar